Columbia Laboratories Inc. (CBRX) Stock Quote

Stock Web

Detailed Quote for Columbia Laboratories Inc. (CBRX)

close 52 Week Information

52 Week High

September 15,2009

Close: 1.59

52 Week Low

November 13,2009

Close: 0.65

Today

5d

1m

3m

1y

more

Last Price
1.0899

Change $
0.0301

Change %
2.69%

Tick

Bid
1.07

Bid Size
2700

Ask
1.08

Ask Size
200

Open
1.13

High
1.13

Low
1.05

Prev Close
1.12

Last Trade
10:16

Volume
15.92 k

52 Wk Hi
1.59

52 Wk Low
0.65

Market Cap
91.7 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
84,134,294

EPS (TTM)
-0.42

PE Ratio
N/A

close Exchange Information Listed On NASDAQ (NSD) Exchange
NSD

News and Media for Columbia Laboratories Inc. (CBRX)

Sector News | Topic News

News for CBRX

Tue, Aug 10, 2010

8:14 AM

Columbia Laboratories Repurchases 3.3 Million Shares of Common Stock - Business Wire

Thu, Aug 05, 2010

6:30 AM

Columbia Laboratories Reports Second Quarter 2010 Financial Results - Business Wire

Tue, Jul 27, 2010

4:00 PM

Columbia Laboratories to Discuss Second Quarter 2010 Financial Results on August 5 Conference Call - Business Wire

Mon, Jul 12, 2010

7:00 AM

Watson Designee Fred Wilkinson Appointed to Columbia Laboratories' Board to Directors - Business Wire

Tue, Jul 06, 2010

7:01 AM

Columbia Laboratories Completes Sale of Progesterone Assets to Watson Pharmaceuticals - Business Wire

Thu, Jul 01, 2010

11:24 AM

Watson Confirms Columbia Laboratories Shareholder Approval of Proposed Acquisition of Progesterone-related Assets - PR Newswire

11:13 AM

Columbia Laboratories Stockholders Approve Sale of Progesterone Assets to Watson Pharmaceuticals - Business Wire

Tue, Jun 08, 2010

7:01 AM

Enrollment Complete in Columbia Laboratories' Phase III Study of PROCHIEVE 8% to Reduce Preterm Birth - Business Wire

Fri, May 14, 2010

8:06 PM

Semi-Annual Changes to the NASDAQ Biotechnology Index - Globe Newswire

More News for CBRX >>

Tags for Columbia Laboratories Inc.

Research stocks or mutual funds related to Columbia Laboratories Inc. by keywords or tags. Find companies that have a similar focus to CBRX. The keywords below have been associated to CBRX by either user submission or electronic means.

biotechnology company pharmaceutical market Commercial Physical And Biological Research (8731) pharmaceuticals companies generic pharmaceutical pharmaceutical investment medical product development biotechnology market pharmaceutical research and development drug delivery technologies pharmaceutical manufacturing company female fertility pharma marketing pharmaceutical industry marketing pharmaceutical software pharma manufacturing pharma license progesterone oil low progesterone generic products progesterone cream drug delivery pharmaceutical cro pharma companies pharma consulting clinical trials industry drug delivery market pharmaceutical distributors pharmaceutical labs pharmaceutical development pharmaceutical reports Drugs pregnancy progesterone supplement pharma r&d infertility treatment infertility infertility causes pharmaceutical manufacturing software pharmaceutical manufacturing pharmaceutical formulation contract pharmaceutical pharmaceutical consulting pharmaceutical industry crinone pharmaceutical studies pharmaceutical advances pharmaceutical distributor pharmaceutical out licensing pharmaceutical business development multinational pharmaceutical companies

Bookmark With:

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.